USP to establish site in India

EPP News Bureau - Mumbai

The United States Pharmacopeia (USP) has announced setting up of a USP-India site. According to a release issued by USP, the site will consist of business operations and laboratories and will offer USP’s broad range of pharmacopeial services to Indian pharmaceutical manufacturers in India as well as surrounding countries.

This will be the first time the organisation has established a USP-based laboratory outside of the US. This decision supports USP’s global public health strategy and will help fulfill USP’s mission: to promote the public health by disseminating authoritative standards and information for medicines, other healthcare technologies and related practices used to maintain and improve health and promote optimal health care delivery. The USP-India site will support the activities of Indian and regional constituencies including the Indian pharmacopoeia, to promote the manufacture of good quality therapeutic products globally, the release added.

USP will work with Indian manufacturers, as it does with other US and multinational manufacturers, to supply good quality, safe and effective medicines and dietary supplement ingredients and products for the US market. Currently, Indian pharmaceutical manufacturers supply bulk ingredients and dosage forms to the US.

‘‘USP looks forward to working more closely with the Indian pharmacopeia, the Indian pharmaceutical industry, Indian drug regulatory authorities and Indian scientists,’’ said Roger L Williams, executive vice-president and chief executive officer in the release.